HomeATHJF • OTCMKTS
add
Percheron Therapeutics Ltd
Previous close
$0.050
Day range
$0.010 - $0.010
Year range
$0.010 - $0.088
Market cap
61.00M AUD
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Market news
Financials
Income Statement
Revenue
Net income
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 600.05K | 143.24% |
Operating expense | 2.95M | 2.71% |
Net income | -2.37M | 10.05% |
Net profit margin | -395.24 | 63.02% |
Earnings per share | — | — |
EBITDA | -2.37M | 10.03% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 17.19M | 3.43% |
Total assets | 19.98M | 10.18% |
Total liabilities | 3.53M | 69.24% |
Total equity | 16.45M | — |
Shares outstanding | 901.54M | — |
Price to book | 2.50 | — |
Return on assets | -29.65% | — |
Return on capital | -35.98% | — |
Cash Flow
Net change in cash
(AUD) | Dec 2023info | Y/Y change |
---|---|---|
Net income | -2.37M | 10.05% |
Cash from operations | -2.37M | -86.44% |
Cash from investing | -3.29K | 71.06% |
Cash from financing | 5.49M | 26,216.37% |
Net change in cash | 3.11M | 338.51% |
Free cash flow | -1.41M | 8.92% |
About
CEO
Founded
2000
Headquarters
Website
Employees
8